These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U; J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896 [TBL] [Abstract][Full Text] [Related]
12. Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis. Yagi R; Kawabata S; Ikeda N; Nonoguchi N; Furuse M; Katayama Y; Kajimoto Y; Kuroiwa T World J Surg Oncol; 2017 Sep; 15(1):179. PubMed ID: 28962578 [TBL] [Abstract][Full Text] [Related]
13. Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors. Schwake M; Kaneko S; Suero Molina E; Müther M; Schipmann S; Köchling M; Brentrup A; Stummer W Acta Neurochir (Wien); 2019 Oct; 161(10):2099-2105. PubMed ID: 31435824 [TBL] [Abstract][Full Text] [Related]
14. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781 [TBL] [Abstract][Full Text] [Related]
15. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535 [TBL] [Abstract][Full Text] [Related]
16. Quantification of PpIX-fluorescence of cerebral metastases: a pilot study. Knipps J; Fischer I; Neumann LM; Rapp M; Dibué-Adjei M; Freiin von Saß C; Placke JM; Mijderwijk HJ; Steiger HJ; Sabel M; Cornelius JF; Kamp MA Clin Exp Metastasis; 2019 Oct; 36(5):467-475. PubMed ID: 31376098 [TBL] [Abstract][Full Text] [Related]
17. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas. Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128 [TBL] [Abstract][Full Text] [Related]
18. Red-light excitation of protoporphyrin IX fluorescence for subsurface tumor detection. Roberts DW; Olson JD; Evans LT; Kolste KK; Kanick SC; Fan X; Bravo JJ; Wilson BC; Leblond F; Marois M; Paulsen KD J Neurosurg; 2018 Jun; 128(6):1690-1697. PubMed ID: 28777025 [TBL] [Abstract][Full Text] [Related]
19. 5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas. Bunk EC; Wagner A; Stummer W; Senner V; Brokinkel B J Neurooncol; 2021 Mar; 152(1):37-46. PubMed ID: 33389565 [TBL] [Abstract][Full Text] [Related]
20. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas. Ma R; Watts C Acta Neurochir (Wien); 2016 Oct; 158(10):1935-41. PubMed ID: 27496021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]